HALOZYME THERAPEUTICS, INC. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
144
25
3
3/A
4
4/A
424A
424B3
424B5
5
8-A12B
8-A12B/A
8-A12G
8-K
8-K/A
ARS
CERTAMX
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14C
EFFECT
NT 10-Q
POS AM
PRE 14A
PREM14C
REGDEX
S-3
S-3ASR
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 - | 0001179110-21-003974 | Apr 1, 2021 | — |
| DEF 14A | DEF 14A PROXY | 0001159036-21-000019 | Mar 26, 2021 | Dec 31, 2020 |
| DEFA14A | DEFA14A PROXY ADDITIONAL MATERIALS | 0001159036-21-000020 | Mar 26, 2021 | — |
| 4 | FORM 4 - | 0001179110-21-002560 | Mar 2, 2021 | — |
| 4 | FORM 4 - | 0001179110-21-002487 | Mar 1, 2021 | — |
| 8-K | 8-K | 0001193125-21-063401 | Mar 1, 2021 | — |
| 4 | FORM 4 - | 0001179110-21-002485 | Mar 1, 2021 | — |
| 4 | FORM 4 - | 0001179110-21-002486 | Mar 1, 2021 | — |
| 8-K | 8-K | 0001193125-21-055596 | Feb 25, 2021 | Feb 24, 2021 |
| 8-K | 8-K | 0001159036-21-000013 | Feb 23, 2021 | — |
| 10-K | 10-K | 0001159036-21-000014 | Feb 23, 2021 | Dec 31, 2020 |
| 8-K | 8-K | 0001193125-21-052372 | Feb 23, 2021 | — |
| 4 | FORM 4 - | 0001179110-21-002056 | Feb 22, 2021 | — |
| 4 | FORM 4 - | 0001179110-21-002057 | Feb 22, 2021 | — |
| 4 | FORM 4 - | 0001179110-21-001811 | Feb 17, 2021 | Feb 15, 2021 |
| 4 | FORM 4 - | 0001179110-21-001808 | Feb 17, 2021 | Feb 15, 2021 |
| 4 | FORM 4 - | 0001179110-21-001807 | Feb 17, 2021 | Feb 15, 2021 |
| 4 | FORM 4 - | 0001179110-21-001809 | Feb 17, 2021 | Feb 15, 2021 |
| 4 | FORM 4 - | 0001179110-21-001686 | Feb 16, 2021 | Feb 14, 2021 |
| 4 | FORM 4 - | 0001179110-21-001690 | Feb 16, 2021 | Feb 14, 2021 |
| 4 | FORM 4 - | 0001179110-21-001653 | Feb 12, 2021 | Feb 10, 2021 |
| SC 13G/A | SC 13G/A | 0001193125-21-041806 | Feb 12, 2021 | — |
| 4 | FORM 4 - | 0001179110-21-001651 | Feb 12, 2021 | Feb 10, 2021 |
| 4 | FORM 4 - | 0001179110-21-001652 | Feb 12, 2021 | Feb 10, 2021 |
| SC 13G/A | HALOZYME THERAPEUTICS INC | 0001193125-21-035231 | Feb 10, 2021 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-21-018229 | Feb 10, 2021 | — |
| 4 | FORM 4 - | 0001179110-21-001007 | Feb 1, 2021 | — |
| 4 | FORM 4 - | 0001179110-21-001008 | Feb 1, 2021 | — |
| SC 13G/A | — | 0000834237-21-001420 | Jan 26, 2021 | — |
| 8-K | 8-K | 0001159036-21-000006 | Jan 13, 2021 | — |
| 8-K | 8-K | 0001159036-21-000003 | Jan 11, 2021 | — |
| 4 | FORM 4 - | 0001179110-21-000059 | Jan 4, 2021 | — |
| 4 | FORM 4 - | 0001179110-20-012141 | Dec 21, 2020 | — |
| SC 13G | — | 0000834237-20-010566 | Dec 8, 2020 | — |
| 4 | FORM 4 - | 0001179110-20-011734 | Dec 7, 2020 | — |
| 4 | FORM 4 - | 0001179110-20-011550 | Dec 2, 2020 | — |
| 4 | FORM 4 - | 0001179110-20-011475 | Nov 30, 2020 | — |
| 4 | FORM 4 - | 0001179110-20-011448 | Nov 27, 2020 | Nov 25, 2020 |
| 4 | FORM 4 - | 0001179110-20-011428 | Nov 25, 2020 | — |
| 4 | FORM 4 - | 0001179110-20-011427 | Nov 25, 2020 | — |
| 4 | FORM 4 - | 0001179110-20-011426 | Nov 25, 2020 | — |
| 4 | FORM 4 - | 0001179110-20-011277 | Nov 20, 2020 | — |
| 8-K | 8-K | 0001159036-20-000043 | Nov 2, 2020 | — |
| 10-Q | 10-Q | 0001159036-20-000044 | Nov 2, 2020 | Sep 30, 2020 |
| 4 | FORM 4 - | 0001179110-20-010606 | Oct 20, 2020 | — |
| 4 | FORM 4 - | 0001179110-20-009905 | Sep 21, 2020 | — |
| 4 | FORM 4 - | 0001179110-20-009727 | Sep 14, 2020 | Sep 11, 2020 |
| 4 | FORM 4 - | 0001179110-20-009605 | Sep 4, 2020 | — |
| 4 | FORM 4 - | 0001179110-20-009192 | Aug 20, 2020 | — |
| 4 | FORM 4 - | 0001179110-20-009047 | Aug 14, 2020 | — |